Hemavathi K N

Ms. Hemavathi K N

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2024 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
HNHemavathi K N
Hemavathi K N
SSSinosh Skariyachan
Sinosh Skariyachan
RRRajesh Raju
Rajesh Raju
TPT. S. Keshava Prasad
T. S. Keshava Prasad
CAChandran S. Abhinand
Chandran S. Abhinand

25 March 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
ARAkhila Balakrishna Rai
Akhila Balakrishna Rai
JCJalaluddin Akbar Kandel Codi
Jalaluddin Akbar Kandel Codi
GSGiridhara Prema Suchitha
Giridhara Prema Suchitha
HNHemavathi K N
Hemavathi K N
SDShobha Dagamajalu
Shobha Dagamajalu
TPT. S. Keshava Prasad
T. S. Keshava Prasad
Growth differentiation factor-15 (GDF15) is a cytokine/growth factor that belongs to the Transforming growth factor-ß (TGF-ß) protein family. The expression of GDF15 is low in most human organs under normal conditions. GDF15 is a stress-responsive cytokine primarily produced by macrophages in response to inflammatory stimuli. The altered expression of GDF15 is associated with many cancers due to the inflammation caused by the disease. GDF15 triggers the activity through its receptor Glial-derived neurotrophic factor-family receptor α-like (GFRAL) and mediates multiple downstream signaling cascades, which are involved in the progression of cancers. Considering the biological importance of GDF15 in different cancers, we applied data mining techniques to systematically compile and analyze the signaling events associated with GDF15 using NetPath criteria. This resulted in constructing a detailed GDF15-mediated signaling pathway map, enhancing our understanding of its molecular mechanisms in cancer. Furthermore, proteins linked to colorectal and breast cancer identified in our pathway map were cross-referenced with established cancer pathway databases to identify unannotated proteins, highlighting gaps in the current annotations. To investigate potential therapeutic strategies, we performed molecular docking simulations and identified Vitisifuran B as a novel inhibitor that could block the GDF15-GFRAL interaction. These findings suggest that Vitisifuran B could effectively modulate GDF15 signaling, offering a promising avenue for cancer therapeutics. This study underscores the power of computational approaches, such as data mining and molecular docking, in enhancing our understanding of GDF15 signaling in cancer and identifying potential inhibitors for therapeutic development.

31 May 2024 in Kuwait Journal of Science
Verified
Journal Article
Open access
TUTalambedu Usha
Talambedu Usha
HNHemavathi K N
Hemavathi K N
AGArvind Kumar Goyal
Arvind Kumar Goyal
CAC.S. Abhinand
C.S. Abhinand
SDS. Dhivya
S. Dhivya
SMSushil Middha
Sushil Middha

22 May 2026 in European Journal of Medicinal Chemistry Reports
Verified
Journal Article
Open access
HNHemavathi K N
Hemavathi K N
SMSushil Kumar Middha
Sushil Kumar Middha
RPRavishankar Pervaje
Ravishankar Pervaje
TPThottethodi Subramanya Keshava Prasad
Thottethodi Subramanya Keshava Prasad
SDShobha Dagamajalu
Shobha Dagamajalu